Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Inclusion Criteria

• •Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 2.
• •Have previously untreated and histological examination confirms resectable stage II-IIIA/IIIB non-small cell lung cancer (according to the 8th edition of the AJCC TNM staging criteria), and the pathological type of squamous cell carcinoma and non-squamous cell carcinoma needs to be distinguished, and EGFR, ALK, and ROS1 should be negative for non-squamous non-small cell lung cancer
• •Adequate organ function and expected survival time ≥ 12 weeks;
• •Evidence of post-menopausal status or negative urinary or serum pregnancy test for female pre-menopausal patients.